TLSI.NASDAQTrisalus Life Sciences, INC

Form 4: TriSalus Officer Sells Shares for Tax Obligations

Sentiment:

Insider Transaction Report

📋All filings for Trisalus Life Sciences, INC
🔒Login to Follow

TriSalus Life Sciences' Chief Regulatory Officer, Jennifer Stevens, sold common stock totaling 3,530 shares to cover tax withholding obligations related to restricted stock unit vesting.

Summary

  • Jennifer Stevens, Chief Regulatory Officer of TriSalus Life Sciences, Inc. (TLSI), reported sales of common stock.
  • The transactions occurred on March 11, 2026, March 12, 2026, and March 16, 2026.
  • A total of 3,530 shares were sold across these three dates.
  • The sales were explicitly stated as non-discretionary, solely to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units.
  • Following these transactions, Jennifer Stevens beneficially owns 124,110 shares of TriSalus Life Sciences, Inc. Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale of shares was explicitly stated as non-discretionary and solely for tax withholding obligations related to RSU vesting, which is a common occurrence for executives and does not reflect a change in company fundamentals.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that routine insider sales for tax purposes, such as those related to restricted stock unit vesting, are common practice across industries and generally do not indicate a shift in management's confidence in the company's future prospects or broader industry trends.

Stakeholder Impact

  • Shareholders may observe a minor reduction in insider ownership, but the non-discretionary nature of the sale for tax purposes is unlikely to significantly impact perceptions of management's commitment or confidence in the company.

Key Dates

DateDescription
03/11/2026Sale of 1,204 shares of Common Stock by Jennifer Stevens at $4.13 per share.
03/12/2026Sale of 1,552 shares of Common Stock by Jennifer Stevens at $4.09 per share.
03/16/2026Sale of 774 shares of Common Stock by Jennifer Stevens at $4.12 per share.
03/20/2026Date the Form 4 was signed by the attorney-in-fact for Jennifer Stevens.

Recommendation

hold

The reported transactions are non-discretionary sales by an officer to cover tax obligations associated with the vesting of restricted stock units. This is a routine event and does not provide new information regarding the company's operational performance, strategic direction, or management's outlook that would warrant a change in investment recommendation.

Keywords

TriSalus Life Sciences, TLSI, Form 4, Insider Transaction, Stock Sale, Restricted Stock Units, Tax Withholding, Jennifer Stevens, Chief Regulatory Officer

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.